Imatinib Completed Phase 2 Trials for Recurrent Colon Cancer / Recurrent Rectal Cancer / Stage IV Colon Cancer / Stage IV Rectal Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00041340Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer